ＪＣＲファーマ(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4552/E00973JCR Pharmaceuticals Co., Ltd.
公表日公表担保新規貸付前週比新規借入（自己）前週比新規借入（転貸）前週比
2020/05/29日証協無担保0株-100%0株-100%602株-80.11%
2020/05/29日証協有担保78,119株+151.7%7,380株+67.73%25,800株-38.57%
2020/05/22日証協無担保200株0%100株0%3,026株+131.52%
2020/05/22日証協有担保31,036株-59.87%4,400株-92.04%42,000株-61.89%
2020/05/15日証協無担保0株-100%0株0%1,307株+225.94%
2020/05/15日証協有担保77,341株+481.95%55,300株+448.61%110,200株+792.6%
2020/05/08日証協無担保300株0%0株0%401株+90.95%
2020/05/08日証協有担保13,290株-52.58%10,080株-2.31%12,346株-43.51%
2020/05/01日証協無担保300株-91.67%0株0%210株-94.51%
2020/05/01日証協有担保28,029株-68.34%10,318株-47.9%21,854株-89.4%
2020/04/24日証協無担保3,600株0%0株0%3,826株+1175.33%
2020/04/24日証協有担保88,542株-10.85%19,804株+670.58%206,150株+74.12%
2020/04/17日証協無担保0株0%0株-100%300株-0.33%
2020/04/17日証協有担保99,323株+45.87%2,570株-92.6%118,392株+45%
2020/04/10日証協無担保0株-100%3,000株0%301株-98.77%
2020/04/10日証協有担保68,091株-17.09%34,724株+194.52%81,651株-9.9%
2020/04/03日証協無担保100株0%0株0%24,378株+2332.93%
2020/04/03日証協有担保82,122株+508.9%11,790株-65.12%90,622株+685.29%
2020/03/27日証協無担保0株0%0株0%1,002株+234%
2020/03/27日証協有担保13,487株+12.2%33,797株+40.91%11,540株-80.84%
2020/03/19日証協無担保0株-100%0株0%300株-78.59%
2020/03/19日証協有担保12,020株-67.56%23,984株+1.62%60,219株-18.08%
2020/03/13日証協無担保500株-66.67%0株0%1,401株+39.96%
2020/03/13日証協有担保37,052株-28.03%23,602株-63.12%73,513株-0.15%
2020/03/06日証協無担保1,500株+114.29%0株0%1,001株-37.44%
2020/03/06日証協有担保51,484株-50.54%64,001株+270.12%73,621株+20.5%
2020/02/28日証協無担保700株-56.25%0株0%1,600株-0.93%
2020/02/28日証協有担保104,099株+44.94%17,292株-69.99%61,097株+10.8%
2020/02/21日証協無担保1,600株0%0株0%1,615株+9999.99%
2020/02/21日証協有担保71,822株-48.45%57,625株+111.86%55,142株+70.2%
2020/02/14日証協無担保0株0%0株-100%3株-99.73%
2020/02/14日証協有担保139,330株-7.47%27,200株+94.29%32,398株-52.94%
2020/02/07日証協無担保0株0%303株0%1,101株+171.18%
2020/02/07日証協有担保150,586株+37.67%14,000株-52.55%68,850株+122.82%
2020/01/31日証協無担保0株-100%0株-100%406株-71.1%
2020/01/31日証協有担保109,381株+463.09%29,502株+315.52%30,900株+65.24%
2020/01/24日証協無担保1,100株+175%203株+6666.67%1,405株-92.84%
2020/01/24日証協有担保19,425株-83.92%7,100株-58.25%18,700株-68.85%

※株式分割は考慮していませんのでご注意ください。

Page Top